Overexpression of phospholipase D enhances Bcl-2 expression by activating STAT3 through independent activation of ERK and p38MAPK in HeLa cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 6, 2012, Pages 1082-1091

  Choi, Hye Jin ^a   Han, Joong Soo ^a  

^a Hanyang University   (South Korea)

Author keywords

Bcl 2; MAPK; Phosphatidic acid (PA); Phospholipase D (PLD); RhoA; STAT3 (ser727)

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; PROTEIN BCL 2; RAC1 PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PHOSPHOLIPASES A2; PROTO-ONCOGENE PROTEINS C-BCL-2; RAC1 GTP-BINDING PROTEIN; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84860304279     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.03.015     Document Type: Article

References (70)

1. Tsujimoto Y., Bashir M.M., Givol I., Cossman J., Jaffe E., Croce C.M. DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:1329-1331.
2. Hockenbery D., Nunez G., Minniman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 22:334-336.
3. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993, 53:4701-4714.
4. Korsmeyer S.J., Danial N.N. Cell death: critical control points. Cell 2004, 116:205-219.
5. Cory S., Adams J.M. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 2001, 26:61-66.
6. Ferguson-Miller S., Newmeyer D.D. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003, 481-490.
7. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J. Cell. Physiol. 2003, 195:158-167.
8. Harris A.W., O'Reilly L.A., Strasser A. Bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8-T cell progenitors. Int. Immunol. 1997, 9:1291-1301.
9. Lu Q.L., Lu P.J., Rughetti A., Taylor-Papadimitriou J. Bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J. Cell Biol. 1995, 129:1363-1378.
10. Kitada S., Miyashita T., Krajewski S., Horne W.A., Delia D., Reed J.C. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J. Biol. Chem. 1995, 270:26049-26052.
11. Cho J.H., Hong S.K., Kim E.Y., Park S.Y., Park C.H., Kim J.M., Kwon O.J., Kwon S.J., Lee K.S., Han J.S. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. Biochim. Biophys. Acta 2008, 1783:912-923.
12. Oh K.J., Lee S.C., Choi H.J., Oh D.Y., Kim S.C., Min do S., Kim J.M., Lee K.S., Han J.S. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J. Cell. Biochem. 2007, 101:1409-1422.
13. Liscovitch M., Czarny M., Fiucci G., Lavie Y., Tang X. Localization and possible functions of phospholipase D isozymes. Biochim. Biophys. Acta 1999, 1439:245-263.
14. Sung Tsung-Chang, Colley William C., Roll Richard, Jenco John, Hammond Scott M., Altshuller Yelena, Bar-Sagi Dafna, Morris Andrew J., Frohman Michael A. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr. Biol. 1997, 7:191-201.
15. Morgan C., Jones D., Cockcroft S. Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta 1999, 1439:229-244.
16. Park S.Y., Cho J.H., Oh D.Y., Park J.W., Ahn M.J., Han J.S., Oh J.W. House dust mite allergen Der f 2-induced phospholipase D1 activation is critical for the production of interleukin-13 through activating transcription factor-2 activation in human bronchial epithelial cells. J. Biol. Chem. 2009, 284:20099-20110.
17. N.Y. Nakashima S, Biochimica et Biophysica Acta, Chem Phys Lipids, 98 (1999) 153-164.
18. Tanabe Kumiko, Yamaguchi Shinobu, Takai Shinji, Matsushima-Nishiwaki Rie, Adachi Seiji, Iida Hiroki, Kozawa Osamu, Dohi Shuji Involvement of Rho-kinase in tumor necrosis factor-a-induced interleukin-6 release from C6 glioma cells. Neurochem. Int. 2009, 55:438-445.
19. Amano Mutsuki, Kaibuchi Kozo, Fukata Yuko Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 2001, 22:32-39.
20. Wakelam Michael J.O., Powner Dale J. The regulation of phospholipase D by inositol phospholipids and small GTPases. FEBS Lett. 2002, 531:62-64.
21. Takai Shinji, Tokudaa Haruhiko, Matsushima-Nishiwaki Rie, Hanaia Yoshiteru, Adachi Seiji, Minamitani Chiho, Mizutani Jun, Otsuka Takanobu, Kozawa Osamu Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79:41-46.
22. Hall A., Etienne-Manneville S. The regulation of phospholipase D by inositol phospholipids and small GTPases. Nature 2002, 420:629-635.
23. Gutiérrez-Uzquiza A., Zuluaga S., Bragado P., Alvarez-Barrientos A., Benito M., Nebreda A.R., Porras A. p38alpha MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum. FEBS Lett. 2007, 581:3819-3825.
24. Li Zhenyu, Flevaris Panagiotis, Zhang Guoying, Zheng Yi, Liu Junling, Du Xiaoping Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 2009, 113:893-901.
25. Strum Jay C., Ghosh Sujoy, Sciorra Vicki A., Daniel Larry, Bell Robert M. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells. J. Biol. Chem. 1996, 14:8472-8480.
26. Shome Kuntala, Rizzo Mark A., Watkins Simon C., Romero Guillermo The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J. Biol. Chem. 2000, 31:23911-23918.
27. Morisset Jean, Boucher Marie-Josée, Vachon Pierre H., Reed John C., Lainé Jean, Rivard Nathalie MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell. Biochem. 2000, 79:355-369.
28. Uchida E., Chung J., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997, 11:6508-6516.
29. Cao Xinmin, Lim Cheh Peng Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 1999, 43:31055-31061.
30. Bowman Tammy, Turkson James, Adnane Jalila, Zhang Yi, Djeu Julie Y., Sekharam Madhavi, Frank David A., Holzman Lawrence B., Wu Jie, Sebti Said, Jove Richard Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol. Cell. Biol. 1999, 11:7519-7528.
31. Jaeschke A., Davis R.J. Metabolic stress signaling mediated by mixed-lineage kinases. Mol. Cell 2007, 27:498-508.
32. Exton John H., Ha Kwon-Soo Activation of actin polymerization by phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts. J. Cell Biol. 1993, 123:1789-1796.
33. Roberts Sally, Cross Michael J., Ridley Anne J., Hodgkin Matthew N., Stewart L.C.-W.Allison, Wakelam Michael J.O. Stimulation of actin stress fibre formation mediated by activation of phospholipase D. Curr. Biol. 1999, 6:588-597.
34. Ghelli A., Porcellia Anna M., Hreliab Silvana, Rugoloa Michela Phospholipase D stimulation is required for sphingosine-1-phosphate activation of actin stress fibre assembly in human airway epithelial cells. Cell. Signal. 2002, 14:75-81.
35. Gibbs Terra C., Xie Yuhuan, Mukhin Yurii V., Meiez Kathryn E. Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 2002, 277:32516-32526.
36. Gill J.S., Tou Jen-sie Lysophosphatidic acid increases phosphatidic acid formation, phospholipase D activity and degranulation by human neutrophils. Cell. Signal. 2005, 17:77-82.
37. Cummings R., Wang L., Usatyuk P., Morris A., Irani K., Natarajan V. Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem. J. 2002, 367(Pt3):751-760.
38. Shirai H., Autieri Michael, Eguchi Satoru Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr. Opin. Nephrol. Hypertens. 2007, 16:111-115.
39. Matarrese P., Fiorentinia Carla, Strafacea Elisabetta, Falzanoa Loredana, Fabbria Alessia, Donellia Gianfranco, Cossarizzab Andrea, Boquetc Patrice, Malornia Walter Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp. Cell Res. 1998, 242:341-350.
40. C.M.-A., Gómez Javier, Giry Murielle, García Alphonse, Rebollo Angelita Rho prevents apoptosis through Bcl-2 expression: implications for interleukin-2 receptor signal transduction. Eur. J. Immunol. 1997, 11:2793-2799.
41. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 1997, 17:6508-6516.
42. Lim C.P., Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J. Biol. Chem. 1999, 274:31055-31061.
43. Lee K.-H., Kim Kyung-Ok, Kim Young-Hoon, Park Seung-Kiel, Han Joong-Soo Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death. Exp. Mol. Med. 2003, 35:38-45.
44. Ohguchi Kenji, Kasai Takeshi, Nakashima Shigeru, Ito Yuzuru, Naganawa Takashi, Kondo Naomi, Nozawa Yoshinori Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells. J. Immunol. 1998, 16:6469-6474.
45. Banno Y., Iwasaki-Bessho Y., Yoshimura S., Ito Y., Kitajima Y., Nozawa Y. Decreased phospholipase D (PLD) activity in ceramide-induced apoptosis of human keratinocyte cell line HaCaT. J. Invest. Dermatol. 1998, 110:376-382.
46. Shin I., Kang J.H., Han J.S. Changes of phospholipase D activity in TNF-alpha and anti-Fas/Apo1 monoclonal antibody induced apoptosis in HL-60 and A20 cells. Exp. Mol. Med. 1998, 30:21-27.
47. Langel-Peveri P., Erickson R.W., Traynor-Kaplan A.E., Heyworth P.G., Curnutte J.T. Activation of human neutrophil NADPH oxidase by phosphatidic acid or diacylglycerol in a cell-free system. Activity of diacylglycerol is dependent on its conversion to phosphatidic acid. J. Biol. Chem. 1999, 32:22243-22250.
48. van Meeteren L.A., Moolenaar W.H., Giepmans B.N. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004, 8:870-881.
49. Haney N., Hu X., Kropp D., Kabore A.F., Johnston J.B., Gibson S.B. Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB. J. Biol. Chem. 2005, 10:9498-9508.
50. Wang D.A., Deng W., Gosmanova E., Johnson L.R., Tigyi G. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G821-G829.
51. Contos J.J., Ishii I., Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 2000, 58:1188-1196.
52. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 2002, 54:265-269.
53. Fukushima N., Ishii I., Contos J.J., Weiner J.A., Chun J. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 2001, 41:507-534.
54. Boketoft A., Kotarsky K., Bristulf J., Nilsson N.E., Norberg A., Hansson S., Owman C., Sillard R., Leeb-Lundberg L.M., Olde B. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J. Pharmacol. Exp. Ther. 2006, 318:619-628.
55. Satoshi I., Noguchi K., Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 2003, 278:25600-25606.
56. Baba K., Tabata K., Shiraishi A., Ito M., Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 2007, 363:861-866.
57. Ishii I., Yang A.H., Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta 2002, 1582:197-203.
58. Means C., Hilal-Dandan R., Gustafsson A.B., Morissette M.R., Adams J.W., Brunton L.L., Heller Brown J. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J. Mol. Cell. Cardiol. 2004, 36:481-493.
59. Moolenaar W.H., Kranenburg O., Postma F.R., Zondag G.C. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 1997, 9:168-173.
60. Murga C., Zohar M., Teramoto H., Gutkind J.S. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 2002, 21:207-216.
61. Le S.S., Loucks F.A., Udo H., Richardson-Burns S., Phelps R.A., Bouchard R.J., Barth H., Aktories K., Tyler K.L., Kandel E.R., Heidenreich K.A., Linseman D.A. Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J. Neurochem. 2005, 94:1025-1039.
62. Schurmann A., Mooney A.F., Sanders L.C., Sells M.A., Wang H.G., Reed J.C., Bokoch G.M. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 2000, 20:453-461.
63. Shibata R., Kai H., Seki Y., Kusaba K., Takemiya K., Koga M., Jalalidin A., Tokuda K., Tahara N., Niiyama H., Nagata T., Kuwahara F., Imaizumi T. Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis. J. Cardiovasc. Pharmacol. 2003, 42(Suppl. 1):S43-S47.
64. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
65. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
66. Alas S., Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res. 2001, 61:5137-5144.
67. Bhattacharya S., Ray R.M., Johnson L.R. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem. J. 2005, 392:335-344.
68. Choi H.J., Lee J.H., Park S.Y., Cho J.H., Han J.S. STAT3 is involved in phosphatidic acid-induced Bcl-2 expression in HeLa cells. Exp. Mol. Med. 2009, 41:94-101.
69. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Oshiro M., Kothapalli R., Li Y., Wang J.M., Yang-Yen H.F., Karras J., Jove R., Loughran T.P. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 2001, 107:351-362.
70. Stephanou A., Brar B.K., Knight R.A., Latchman D.S. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 2000, 7:329-330.